ArticleJMIR mHealth and uHealth2026
A Metaverse Program to Prevent E-Cigarette Use Among Adolescents: Pilot Mixed Methods Study.
Article in JMIR mHealth and uHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: E-cigarette use among adolescents presents challenges distinct from traditional smoking issues. The perception that e-cigarettes are less harmful and their distinctive appeal as a means of sensation seeking among adolescents suggest that traditional smoking prevention programs may not guarantee effectiveness in preventing e-cigarette use. Therefore, there is an urgent need for educational interventions to prevent adolescents from using e-cigarettes. Objective: This pilot study aimed to assess the potential of the Meta Nodam program, a novel metaverse-based educational initiative to enhance adolescents' resistance to e-cigarette use and increase their engagement in preventive education. Methods: The Meta Nodam program was developed on the Roblox platform, designed to promote autonomous engagement and health-related decision-making among adolescents. The study included 120 participants in a 2-session intervention over 2 weeks, each session lasting 45 minutes. Changes in key cognitive outcomes (e-cigarette use intentions, attitudes, norms, self-efficacy, and interest development) were examined using pre- and postintervention surveys. In addition, focus group interviews with 10 participants were conducted to gain deeper insights into participants' experiences. Results: Quantitative analysis showed a significant within-group increase in e-cigarette-related self-efficacy (t119=-3.171; P=.002), whereas no statistically significant pretest-posttest differences were observed in intentions (t119=-0.846; P=.40) or attitudes (t119=-0.080; P=.94). Qualitative findings explained and expanded these results by indicating that immersive metaverse experiences made e-cigarette-related risks more tangible, encouraged peer discussion, and promoted reflection on e-cigarette-related decision-making. Participants also described the program as engaging and reported interest in further exploring information about the health risks of e-cigarette use. Conclusions: Owing to the short duration of the metaverse experience, limited to 2 sessions over 2 weeks, the program did not measurably alter adolescents' attitudes or intentions regarding e-cigarette use. However, it was associated with enhanced e-cigarette-related self-efficacy and demonstrated the applicability, usefulness, and attractiveness of the metaverse program. This study highlights the potential of digital platforms such as the metaverse for health education, emphasizing user engagement, interaction, and experiential learning in preventive education. Future research should consider broader participant demographics and more robust experimental designs to more rigorously evaluate the potential of such interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.